COMBAT - Updated biosecurity tool with 4 features
The Guilty Gilt Guide
PRRS Ctrl 2.0
The 11th European PRRS Research Awards
3rd European PRRSpective. Improving PRRS resilience in pig farms
21st September, 2017
Professor Yang explains the mechanisms that PRRS uses to evade the pig’s immune system and some of the mistakes we make to help it succeed.
Prof. Hanchun Yang (China Agricultural University) explains how PRRS affects the immune system and how hp PRRS strains evolve and recombine.
Episode 15 - New gilts: Steering the health profile of herd replacements
Don’t miss any news on PRRS disease control Subscribe now to PRRS.com newsletter
“Highly pathogenic African swine fever virus is present in all wild boar in Poland; there are no safe levels of wild boar density”
The use of INGELVAC PRRS vaccines can significantly reduce lung lesions following challenge with heterologous isolates (86- 94% ORF5 nucleotide similarity) in the three-week-old pig respiratory challenge model.1 INGELVAC PRRS MLV demonstrated heterologous protection against challenge with current PRRSV lineage-1 RFLP 1-7-4 and 1-3-4 isolates.2 The objective of this study was to evaluate the efficacy of two commercially available PRRSV vaccines in a three-week-old pig respiratory challenge model, using a heterologous PRRSV lineage-1 RFLP 1-7-4 field strain that was isolated in 2016.
Vaccination against Porcine Reproductive and Respiratory Syndrome virus (PRRSv) is widely used to control clinical disease, but the effectiveness appears in some cases to be suboptimal. Field reports have stated the presence of routinely PRRSv-vaccinated but ELISA seronegative sows: the ELISA non-responders.
1st American PRRSpective - Improving PRRS resilience in pig farms